Augusto Villanueva is Assistant Professor in the Liver Cancer Program (Icahn School of Medicine at Mount Sinai, New York). He received his medical degree from the University of Santiago de Compostela (Spain), and he is board certified in Gastroenterology and Hepatology (Spain). In 2013, we jointed the Institute of Liver Studies at King’s College Hospital in London as Senior Lecturer and Consultant Hepatologist where he was co-leading the HCC Clinic and Multidisciplinary Tumor Board. In 2014 he was recruited at the Icahn School of Medicine at Mount Sinai where he combines clinical activity as a hepatologist, and research focused on the development of novel minimally invasive biomarkers of liver cancer using liquid biopsy. He has more than 125 publications (>13,000 citations, H-index 51) including articles in N Engl J Med, Nat Genet, Nat Biotech, Nat Commun, Gastroenterology, Hepatology, J Hepatol, J Clin Invest, Oncogene, etc. He wrote more than 15 book chapters and edited a book on resistance to targeted therapies in HCC. He served as Associate Editor for J Hepatol and Liver Cancer and he is the current Executive Secretary of the International Liver Cancer Association.
